BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10926814)

  • 21. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
    Bertelli G; Cafferata MA; Ardizzoni A; Gozza A; Rosso R; Dini D
    Cancer; 1997 Jun; 79(11):2266-9. PubMed ID: 9179078
    [No Abstract]   [Full Text] [Related]  

  • 22. Coping with toxicities of docetaxel (Taxotere).
    Schrijvers D; Wanders J; Dirix L; Prove A; Vonck I; van Oosterom A; Kaye S
    Ann Oncol; 1993 Aug; 4(7):610-1. PubMed ID: 8103352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer.
    Laport GG; Fleming GF; Waggoner S; Zimmerman TM; Grinblatt DL; Williams SF
    Bone Marrow Transplant; 2001 Apr; 27(7):677-81. PubMed ID: 11360105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected toxicity after low-dose docetaxel treatment of a cancer patient with clinically latent HCV-positive hepatic cirrhosis.
    Koukourakis MI; Kapsoritakis A; Maltezos E; Potamiano S; Mouzas I; Kouroumalis H
    Anticancer Res; 2002; 22(4):2491-2. PubMed ID: 12174950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Yellow nails].
    Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
    Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
    [No Abstract]   [Full Text] [Related]  

  • 26. Docetaxel (Taxotere): an overview of first-line monotherapy.
    Trudeau ME
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):17-21. PubMed ID: 8604448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Low-dose weekly administration of docetaxel for metastatic breast cancer].
    Kimijima I; Watanabe T; Sagara H; Ohtake T; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):995-9. PubMed ID: 10396330
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of docetaxel-induced erythrodysesthesia with local hypothermia.
    Zimmerman GC; Keeling JH; Lowry M; Medina J; Von Hoff DD; Burris HA
    J Natl Cancer Inst; 1994 Apr; 86(7):557-8. PubMed ID: 7907667
    [No Abstract]   [Full Text] [Related]  

  • 30. Extravasation of docetaxel: a red hand syndrome.
    Barceló R; Viteri A; Muñoz A; Carrera S; Rubio I; López-Vivanco G
    Arch Dermatol; 2005 Oct; 141(10):1326-7. PubMed ID: 16230582
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytotoxic extravasation: an issue disappearing or a problem without solution?
    Ferrari LA; Dinoi GL; Saibene G; Re B; Balzarini A; Giordano L; Sala E; Bregant C
    Tumori; 2016 Jun; 2016(3):290-3. PubMed ID: 27032703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer.
    Kaya AO; Buyukberber S; Coskun U; Yildiz R; Ozturk B; Yaman E; Adisen E; Gureli M; Benekli M
    Cutan Ocul Toxicol; 2008; 27(4):327-31. PubMed ID: 18828046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.
    Chu CY; Yang CH; Yang CY; Hsiao GH; Chiu HC
    Br J Dermatol; 2000 Apr; 142(4):808-11. PubMed ID: 10792238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onycholysis associated with paclitaxel.
    Mackay-Wiggan J; Nair KG; Halasz CL
    Cutis; 2003 Mar; 71(3):229-32. PubMed ID: 12661751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases.
    Battafarano DF; Zimmerman GC; Older SA; Keeling JH; Burris HA
    Cancer; 1995 Jul; 76(1):110-5. PubMed ID: 8630861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).
    Hilkens PH; Verweij J; Vecht CJ; Stoter G; van den Bent MJ
    Ann Oncol; 1997 Feb; 8(2):187-90. PubMed ID: 9093729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Taxane-induced ungual anomalies].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Jan; 127(1):130. PubMed ID: 10717580
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recurrent squamous-cell lung cancer treated with bronchial-arterial infusion of docetaxel--case report].
    Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2109-13. PubMed ID: 9838914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Docetaxel-induced supravenous serpentine dermatitis.
    Ghosh SK; Bandyopadhyay D; Ghoshal L; Basu S
    Dermatol Online J; 2011 Nov; 17(11):16. PubMed ID: 22136872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of docetaxel-induced erythrodysesthesia.
    Katoh M; Kadota M; Nishimura Y
    J Dermatol; 2004 May; 31(5):403-6. PubMed ID: 15187308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.